True North Advisors’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$555K Buy
6,052
+75
+1% +$6.56K 0.05% 168
2026
Q1
$509K Sell
5,977
-186
-3% -$16.6K 0.06% 162
2025
Q4
$487K Sell
6,163
-13
-0.2% -$1.02K 0.06% 156
2025
Q3
$494K Sell
6,176
-629
-9% -$53.7K 0.08% 130
2025
Q2
$619K Sell
6,805
-104
-2% -$9.49K 0.12% 122
2025
Q1
$647K Buy
6,909
+27
+0.4% +$2.42K 0.11% 118
2024
Q4
$626K Sell
6,882
-82
-1% -$7.83K 0.15% 84
2024
Q3
$723K Sell
6,964
-222
-3% -$22.6K 0.19% 78
2024
Q2
$697K Sell
7,186
-21,307
-75% -$1.97M 0.19% 87
2024
Q1
$2.57M Buy
28,493
+10,449
+58% +$885K 0.71% 27
2023
Q4
$1.44M Sell
18,044
-20
-0.1% -$1.5K 0.37% 43
2023
Q3
$1.28M Sell
18,064
-2,033
-10% -$152K 0.4% 48
2023
Q2
$1.55M Buy
20,097
+167
+0.8% +$12.9K 0.44% 51
2023
Q1
$1.5M Hold
19,930
0.44% 53
2022
Q4
$1.57M Hold
19,930
0.54% 47
2022
Q3
$1.4M Sell
19,930
-350
-2% -$27.4K 0.46% 53
2022
Q2
$1.63M Buy
20,280
+238
+1% +$18.6K 0.51% 48
2022
Q1
$1.52M Sell
20,042
-21,125
-51% -$1.67M 0.41% 56
2021
Q4
$3.51M Buy
41,167
+1,221
+3% +$95.3K 0.59% 37
2021
Q3
$3.02M Hold
39,946
0.59% 43
2021
Q2
$3.25M Buy
39,946
+72
+0.2% +$5.89K 0.68% 32
2021
Q1
$3.14M Sell
39,874
-665
-2% -$52.1K 0.75% 29
2020
Q4
$3.47M Sell
40,539
-97
-0.2% -$8.02K 0.89% 27
2020
Q3
$3.13M Buy
40,636
+135
+0.3% +$10.3K 0.91% 26
2020
Q2
$2.97M Buy
40,501
+10,145
+33% +$721K 0.71% 32
2020
Q1
$2.01M Sell
30,356
-1,580
-5% -$111K 0.69% 37
2019
Q4
$2.2M Buy
+31,936
New +$2.18M 0.62% 42

Other funds holding CL

True North Advisors's CL Position: Q2 2026 in Review

True North Advisors increased its Colgate-Palmolive (CL) stake by 1.3% in Q2 2026, buying an estimated $6.56K and bringing the position to 6,052 shares worth $555K. The position accounts for 0.05% of the portfolio, ranked #168.

True North Advisors first reported a position in CL in Q4 2019 and has held it in 27 quarters since. The position peaked at $3.51M in Q4 2021. 623 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • True North Advisors held 6,052 shares of Colgate-Palmolive worth $555K as of Q2 2026.
  • True North Advisors bought 75 Colgate-Palmolive shares in Q2 2026, an estimated $6.56K.
  • Colgate-Palmolive made up 0.05% of True North Advisors's portfolio in Q2 2026, its #168 holding.
  • True North Advisors first reported a position in Colgate-Palmolive in Q4 2019 and has held it in 27 quarters since.
  • True North Advisors's Colgate-Palmolive position peaked at $3.51M in Q4 2021.
  • 623 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on True North Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.